healthy humans
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) 20< of healthy men and women (2) Who gave the informed consents in writing after receiving enough explanation of purpose and detail of the study, understanding the study well, and deciding to attend the study with their own will.
Exclusion criteria
Exclusion criteria: (1) Subjects who has treatment with warfarin. (2) Subjects with the severe disease medical history. (3) Subjects who are judged as inappropriate to be enrolled in this trials by chief investigator or sub investigators
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Blood flow in salivary gland (NIRS) Amount of saliva secretion | — |
Secondary
| Measure | Time frame |
|---|---|
| Biochemical analysis (saliva) alpha-Amylase Hemoglobin LDH sIgA Lysozyme Bacteria test | — |
Countries
Japan
Contacts
Prefectural University of Hiroshima. Department of Physical Therapy, Faculty of Health and Welfare